Condition
Hypogammaglobulinemia, Acquired clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hypogammaglobulinemia, Acquired clinical trials that are recruiting, at sites in 2 countries (most in Canada (1), United States (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Using immunoglobulin to help patients with low antibody levels after CAR T cell therapy
This study is testing if giving immunoglobulin to patients with low antibody levels after CAR T cell therapy can help prevent infections and improve their quality of life.
-
Using IgPro20 to prevent infections in patients with multiple myeloma and low immunoglobulin levels
This study is testing if IgPro20 can help prevent infections in people with multiple myeloma and low immune levels who are receiving certain treatments.
Related topics
Quick answers
How many Hypogammaglobulinemia, Acquired clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Canada (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.